---
title: Improve trunk posture and balance
nct_id: NCT07610031
phase: NA
status: RECRUITING
sponsor: University of Lahore
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07610031"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07610031"
last_fetched: "2026-05-27T14:00:46.733Z"
source: "Parkinson's Pathways (curated)"
---
# Improve trunk posture and balance

**Goal (in five words):** Improve trunk posture and balance

**Official Title:** Effects of Trunk Control Exercises and Mirror Therapy on Balance and Posture in Patients With Parkinson's Disease

**Trial ID:** [NCT07610031](https://clinicaltrials.gov/study/NCT07610031)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** University of Lahore
- **Target Enrollment:** 36 participants
- **Start Date:** 2024-12-22
- **Completion Date:** 2026-06-15
- **Conditions:** Parkinson s Disease
- **Interventions:** Trunk control exercise, Mirror therapy
- **Intervention Types:** OTHER

## Summary For Families

Aiming to reduce balance problems and poor trunk posture that can cause falls and a stooped gait in Parkinson's, this trial tests whether focused core training plus visual feedback can improve upright stability. It combines trunk control exercises to strengthen and coordinate the core muscles that support posture, with mirror therapy that provides visual feedback to retrain movement symmetry and motor patterns; these are rehab approaches meant to complement, not replace, a person’s usual Parkinson’s medications. Looking for people aged 50 to 70 with mild to moderate Parkinson’s (Hoehn and Yahr stages 1,3), on a fixed medication dose, with normal cognition (Mini‑Mental score 24,30), able to rise from a chair without help, and without major dyskinesias, recent seizures or trauma, or unstable cardiovascular disease.

## Eligibility

- **Minimum age:** 50 Years
- **Maximum age:** 70 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* • 50-70 age(Bomasang-Layno et al., 2015)

  * Both genders (Bomasang-Layno et al., 2015)
  * Patient with grade 1,2,3 Parkinsonism (according to Hoehn and Yahr scale)
  * Patient taking fixed dose of medicines
  * No cognitive impairment (according to Mini-Mental scale 24-30 scoring) (Capecci et al., 2014)
  * The patient was able to get out of chairs and beds without assistance (Hoffmann et al., 2016).
  * Individuals without significant dyskinesias or "on-off" periods.(Lötzke et al., 2015)

Exclusion Criteria:

* • Patient having any recent episode of epilepsy(Bomasang-Layno et al., 2015)

  * Patient has had any recent trauma. (Hong et al., 2009)
  * Individuals free from chronic diseases such as unstable cardiovascular disease that could compromise their safety during training or testing (Hoffmann et al., 2016).
```

## Locations (1)

- Nimra Nadeem, Lahore, Punjab Province, Pakistan _(31.5580, 74.3507)_
  - Hafiza Sana Ashraf, MS-MSK — (CONTACT) — 03224866794 — sana.ashraf@uipt.uol.edu.pk
  - Muhammad Asim Arif, MS-MSK, PhD* — (CONTACT) — 03216597727 — asim.arif@uol.edu.pk
  - Nimra Nadeem, MS-MSK — (PRINCIPAL_INVESTIGATOR)

## Central Contacts

- Ishaq Ahmed, PHD — (CONTACT) — 0334 4066 463 — ishaq.ahmed@uipt.uol.edu.pk
- Ashfaq Ahmad, PHD — (CONTACT) — 03009449192 — ashfaq.ahmad@uipt.uol.edu.pk

---

*Canonical: https://parkinsonspathways.com/trial/NCT07610031*  
*HTML version: https://parkinsonspathways.com/trial/NCT07610031*  
*Source data: https://clinicaltrials.gov/study/NCT07610031*